167 related articles for article (PubMed ID: 24402860)
21. Genomic instability signals offer diagnostic possibility in early cancer detection.
Killcoyne S; Yusuf A; Fitzgerald RC
Trends Genet; 2021 Nov; 37(11):966-972. PubMed ID: 34218956
[TBL] [Abstract][Full Text] [Related]
22. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
[TBL] [Abstract][Full Text] [Related]
23. Correlation between dysplasia and mutations of six tumor suppressor genes in Barrett's esophagus.
Raja S; Finkelstein SD; Baksh FK; Gooding WE; Swalsky PA; Godfrey TE; Buenaventura PO; Luketich JD
Ann Thorac Surg; 2001 Oct; 72(4):1130-5. PubMed ID: 11603424
[TBL] [Abstract][Full Text] [Related]
24. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
[TBL] [Abstract][Full Text] [Related]
25. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
[TBL] [Abstract][Full Text] [Related]
26. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
[TBL] [Abstract][Full Text] [Related]
27. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue.
Galipeau PC; Prevo LJ; Sanchez CA; Longton GM; Reid BJ
J Natl Cancer Inst; 1999 Dec; 91(24):2087-95. PubMed ID: 10601379
[TBL] [Abstract][Full Text] [Related]
28. Risk of neoplastic progression in Barrett's esophagus diagnosed as indefinite for dysplasia: a nationwide cohort study.
Kestens C; Leenders M; Offerhaus GJ; van Baal JW; Siersema PD
Endoscopy; 2015 May; 47(5):409-14. PubMed ID: 25521571
[TBL] [Abstract][Full Text] [Related]
29. Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma.
Smith E; De Young NJ; Pavey SJ; Hayward NK; Nancarrow DJ; Whiteman DC; Smithers BM; Ruszkiewicz AR; Clouston AD; Gotley DC; Devitt PG; Jamieson GG; Drew PA
Mol Cancer; 2008 Oct; 7():75. PubMed ID: 18831746
[TBL] [Abstract][Full Text] [Related]
30. Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma.
Paulson TG; Maley CC; Li X; Li H; Sanchez CA; Chao DL; Odze RD; Vaughan TL; Blount PL; Reid BJ
Clin Cancer Res; 2009 May; 15(10):3305-14. PubMed ID: 19417022
[TBL] [Abstract][Full Text] [Related]
31. Biomarkers of Barrett's Esophagus: From the Laboratory to Clinical Practice.
Konda VJA; Souza RF
Dig Dis Sci; 2018 Aug; 63(8):2070-2080. PubMed ID: 29713984
[TBL] [Abstract][Full Text] [Related]
32. Can Genomic Sequencing Identify High-Risk Barrett's Esophagus Earlier Than Pathologists?
Stachler MD; Bass AJ
Cancer Cell; 2020 Nov; 38(5):626-628. PubMed ID: 33171128
[TBL] [Abstract][Full Text] [Related]
33. P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus.
Schneider PM; Stoeltzing O; Roth JA; Hoelscher AH; Wegerer S; Mizumoto S; Becker K; Dittler HJ; Fink U; Siewert JR
Clin Cancer Res; 2000 Aug; 6(8):3153-8. PubMed ID: 10955797
[TBL] [Abstract][Full Text] [Related]
34. Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma.
Zhuang Z; Vortmeyer AO; Mark EJ; Odze R; Emmert-Buck MR; Merino MJ; Moon H; Liotta LA; Duray PH
Cancer Res; 1996 May; 56(9):1961-4. PubMed ID: 8616831
[TBL] [Abstract][Full Text] [Related]
35. Isoforms of RNF128 Regulate the Stability of Mutant P53 in Barrett's Esophageal Cells.
Ray D; Ray P; Ferrer-Torres D; Wang Z; Nancarrow D; Yoon HW; San Martinho M; Hinton T; Owens S; Thomas D; Jiang H; Lawrence TS; Lin J; Lagisetty K; Chang AC; Beer DG
Gastroenterology; 2020 Feb; 158(3):583-597.e1. PubMed ID: 31715145
[TBL] [Abstract][Full Text] [Related]
36. Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett's esophagus.
Li X; Galipeau PC; Paulson TG; Sanchez CA; Arnaudo J; Liu K; Sather CL; Kostadinov RL; Odze RD; Kuhner MK; Maley CC; Self SG; Vaughan TL; Blount PL; Reid BJ
Cancer Prev Res (Phila); 2014 Jan; 7(1):114-27. PubMed ID: 24253313
[TBL] [Abstract][Full Text] [Related]
37. Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma.
Reid BJ; Haggitt RC; Rubin CE; Rabinovitch PS
Gastroenterology; 1987 Jul; 93(1):1-11. PubMed ID: 3582897
[TBL] [Abstract][Full Text] [Related]
38. Minichromosomal Maintenance Component Complex 5 (MCM5) as a Marker of Barrett's Esophagus-Related Neoplasia: A Feasibility Study.
Everson M; Magee C; Alzoubaidi D; Brogden S; Graham D; Lovat LB; Novelli M; Haidry R
Dig Dis Sci; 2019 Oct; 64(10):2815-2822. PubMed ID: 30982210
[TBL] [Abstract][Full Text] [Related]
39. Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases.
Schneider PM; Casson AG; Levin B; Garewal HS; Hoelscher AH; Becker K; Dittler HJ; Cleary KR; Troster M; Siewert JR; Roth JA
J Thorac Cardiovasc Surg; 1996 Feb; 111(2):323-31; discussion 331-3. PubMed ID: 8583805
[TBL] [Abstract][Full Text] [Related]
40. [Demonstration of clonal heterogeneity in adenocarcinomas on Barrett's esophagus by flow cytometric study of cellular DNA content].
Robaszkiewicz M; Volant A; Hardy E; Nousbaum JB; Calament G; Cauvin JM; Bail JP; Lozach P; Gouerou H
Gastroenterol Clin Biol; 1992; 16(6-7):540-6. PubMed ID: 1526415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
